Trial intelligence / Profile preview

Dutasteride versus placebo added to topical clobetasol and minoxidil for lichen planopilaris

IRCT20120215009014N568Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in lichen planopilaris (LPP) comparing Dutasteride arm with Placebo arm (2 arms). Primary endpoint: Clinical symptoms of lichen planopilaris. Started Sep 2025; status: completed.

02

Drugs

dutasteride
03

Conditions

lichen planopilaris (LPP)

Beyond the preview

Go deeper on IRCT20120215009014N568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call